Group 1 - Organon & Co.'s securities are currently undervalued, with a forward P/E ratio of approximately 2.4x compared to the sector average of 17x [1] - Following the separation from Merck, Organon's stock price has fallen below $10 [1] Group 2 - The article emphasizes that a low price does not necessarily indicate a good investment opportunity [1]

Core Viewpoint - Small-cap stocks are experiencing significant growth, with the Russell 2000 Index rising nearly 9% in July 2025, outperforming larger indices like the S&P 500 and Nasdaq Composite [1] Group 1: Market Dynamics - Renewed expectations for Federal Reserve rate cuts due to cooling inflation and a slowing job market are driving small-cap stock performance, as lower rates reduce borrowing costs for these companies [3] - Small-cap stocks are trading at a substantial discount of approximately 55% compared to large-cap stocks based on P/E ratios, prompting institutional investors to shift their focus towards under-owned small-cap areas [4] - A rebound is observed in small-cap companies within the financials, industrials, and consumer discretionary sectors, which collectively represent over 50% of the Russell 2000, particularly benefiting regional banks and manufacturing stocks [5] Group 2: M&A Activity and Investor Sentiment - Increased M&A activity is noted among small and mid-sized firms in healthcare, biotech, and tech services, as large-cap companies seek growth through acquisitions, making small-caps attractive targets [6] - Retail investors are returning to small-cap stocks as recession fears diminish, with trading volumes in small-cap names and ETFs rising due to social media influence and AI-driven trading strategies [7] Group 3: Leading ETFs - Avantis U.S. Small Cap Equity ETF (AVSC) has increased by 10.1%, focusing on a diverse group of 1,287 small-cap stocks, with $1.7 billion in assets under management [9] - Invesco S&P SmallCap Value with Momentum ETF (XSVM) is up 9.5%, tracking high momentum value stocks with a focus on financials, holding 122 stocks and $574.1 million in assets [10] - JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) has risen by 9.4%, providing exposure to 749 small-cap stocks with $566.5 million in assets [11] - iShares US Small Cap Value Factor ETF (SVAL) is up 9%, focusing on 250 small-cap companies with a significant portion in financials, holding $140.8 million in assets [12] - WisdomTree U.S. SmallCap Fund (EES) has increased by 8.7%, targeting 901 small-cap companies with $606.9 million in assets [13]